Ancient Greek and Greco–Roman Methods in Modern Surgical Treatment of Cancer Niki PapavramidouTheodossis PapavramidisThespis Demetriou Breast Oncology Open access 05 January 2010 Pages: 665 - 667
The Marriage Between Pathology and Genetics: Are We Ready for Clinical Use? Angelo P. Dei Tos Bone and Soft Tissue Sarcomas Open access 04 December 2009 Pages: 668 - 669
Who Is to Blame for False-Negative Sentinel Node Biopsies in Melanoma? Vernon K. SondakJonathan S. Zager Melanomas Open access 02 December 2009 Pages: 670 - 673
Computer-Based Learning Module and the Educational Process for Women with Breast Cancer Who Desire Reconstruction Albert Losken Reconstructive Oncology Open access 29 December 2009 Pages: 674 - 675
Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough? Luis J. Herrera Thoracic Oncology Open access 02 December 2009 Pages: 676 - 678
The Value of Intraoperative Parathyroid Hormone Monitoring in Localized Primary Hyperparathyroidism: A Cost Analysis Lilah F. MorrisKyle ZanoccoMichael W. Yeh Healthcare Policy and Outcomes Open access 03 November 2009 Pages: 679 - 685
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience Ronald S. A. de VreezeDaphne de JongFrits van Coevorden Bone and Soft Tissue Sarcomas Open access 19 November 2009 Pages: 686 - 693
Primary Malignant Giant-Cell Tumor of Bone Has High Survival Rate Stepan V. DomovitovJohn H. Healey Bone and Soft Tissue Sarcomas 10 November 2009 Pages: 694 - 701
Differential Presentations, Clinical Courses, and Survivals of Osteosarcomas of the Proximal Humerus over Other Extremity Locations Wan Hyeong ChoWon Seok SongSoo-Yong Lee Bone and Soft Tissue Sarcomas 17 November 2009 Pages: 702 - 708
Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients Charles R. ScogginsRobert C. G. MartinKelly M. McMasters Melanomas 05 December 2009 Pages: 709 - 717
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma Howard L. KaufmanDae Won KimSeunghee Kim-Schulze Melanomas 14 November 2009 Pages: 718 - 730
Feasibility of a Novel Approach to Inguinal Lymphadenectomy: Minimally Invasive Groin Dissection for Melanoma Keith A. DelmanDavid A. KoobyViraj Master Melanomas 17 November 2009 Pages: 731 - 737
Computer-Based Learning Module Increases Shared Decision Making in Breast Reconstruction Bernard T. LeeChen ChenAdam M. Tobias Reconstructive Oncology 29 December 2009 Pages: 738 - 743
Predictive Factors of Response to Decongestive Therapy in Patients with Breast-Cancer-Related Lymphedema Isabel Forner-CorderoJosé Muñoz-LangaJuan M. DeMiguel-Jimeno Breast Oncology 27 October 2009 Pages: 744 - 751
Obesity and Angiolymphatic Invasion in Primary Breast Cancer Erin F. GillespieMelony E. SorberoJennifer J. Griggs Breast Oncology 07 November 2009 Pages: 752 - 759
Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk Ming-Shiean HsuJyh-Cherng YuChun-Wen Cheng Breast Oncology 21 November 2009 Pages: 760 - 771
Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence Sonia PernasMarta GilMiguel Gil Gil Breast Oncology 14 November 2009 Pages: 772 - 777
Ductoscopy in the Evaluation and Management of Nipple Discharge Sedat KamaliÖmer BenderGülçin Kamalı Breast Oncology 11 December 2009 Pages: 778 - 783
How Does the Number of Resected Lymph Nodes Influence TNM Staging and Prognosis for Esophageal Carcinoma? Yang HuChunyan HuLong-Qi Chen Thoracic Oncology 02 December 2009 Pages: 784 - 790
The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal Adenocarcinoma Naveenraj SolomonYing ZhugeLeonidas G. Koniaris Thoracic Oncology 02 December 2009 Pages: 791 - 803
p53 Mutation Status Predicts Pathological Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer Tomoki MakinoMakoto YamasakiYuichiro Doki Thoracic Oncology 03 November 2009 Pages: 804 - 811
A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma Bareld B. PultrumJudith HoningJohn Th. M. Plukker Gastrointestinal Oncology Open access 19 November 2009 Pages: 812 - 820
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer Takeshi YokoeYuji ToiyamaMasato Kusunoki Gastrointestinal Oncology 07 November 2009 Pages: 821 - 828
Clinicopathological Features and Prognostic Factors of Proximal Gastric Carcinoma in a Population with High Helicobacter pylori Prevalence: A Single-Center, Large-Volume Study in Korea Jun Chul ParkYong Chan LeeChoong Bai Kim Gastrointestinal Oncology 31 October 2009 Pages: 829 - 837
Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment? Raffaele LombardiDajana CuicchiBruno Cola Colorectal Cancer 12 December 2009 Pages: 838 - 845
The Adrenal Mass: Correlation of Histopathology with Imaging Linwah YipMitchell E. TublinJohn H. Yim Endocrine Tumors 04 December 2009 Pages: 846 - 852
Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma J. Alejandro Rauh-HainAlexander B. OlawaiyeLinda Duska Gynecologic Oncology 18 November 2009 Pages: 853 - 860
The Role of Pelvic and/or Para-Aortic Lymphadenectomy in Surgical Management of Apparently Early Carcinosarcoma of Uterus Jeong-Yeol ParkDae-Yeon KimJoo-Hyun Nam Gynecologic Oncology 18 November 2009 Pages: 861 - 868
Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection Ju Hyun ShimKang Mo KimDong Jin Suh Hepatobiliary Tumors 22 December 2009 Pages: 869 - 877
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling Makoto SuzukiHironobu WadaIchiro Yoshino Translational Research and Biomarkers 16 October 2009 Pages: 878 - 888
Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene Tsuyoshi TakahashiMakoto SonobeHiroshi Date Translational Research and Biomarkers 21 November 2009 Pages: 889 - 897
Hypoxic Single-Pass Isolated Hepatic Perfusion of Hypotonic Cisplatin: Safety Study in the Pig Pablo Ortega-DeballonOlivier FacyBruno Chauffert Translational Research and Biomarkers 27 October 2009 Pages: 898 - 906
CKS1B Overexpression Implicates Clinical Aggressiveness of Hepatocellular Carcinomas but Not p27Kip1 Protein Turnover: an Independent Prognosticator with Potential p27Kip1-Independent Oncogenic Attributes? Ching-Wen HuangChing-Yih LinYow-Ling Shiue Translational Research and Biomarkers 29 October 2009 Pages: 907 - 922
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis Shuji NomotoMitsuro KandaAkimasa Nakao Translational Research and Biomarkers 07 November 2009 Pages: 923 - 932
Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value? Dimosthenis ZiogasHaralampos HarissisCharalabos Batsis Breast Oncology 15 October 2009 Pages: 933 - 934
Reply to: Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer Masahiro SakakibaraTakeshi NagashimaMasaru Miyazaki Breast Oncology 15 October 2009 Pages: 935 - 935
Micrometastatic Sentinel Lymph Node Disease: Do Patients Benefit or Suffer Harm from Axillary Lymph Node Dissection? D. ZiogasG. C. Zografos Breast Oncology 25 November 2009 Pages: 936 - 937
In Reply: Micrometastases in Breast Cancer Sentinel Lymph Node Ulrich GullerIgor LangerMarkus Zuber Breast Oncology 10 December 2009 Pages: 938 - 938
Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery G. C. ZografosD. H. Roukos Breast Oncology 24 November 2009 Pages: 939 - 939
Author Reply: Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery Amanda ArringtonTodd Tuttle Breast Oncology 24 November 2009 Pages: 940 - 940
Follow-Up for Gastric Cancer: How Extensive and Intensive Should It Be? C. BaliD. H. RoukosD. E. Ziogas Gastrointestinal Oncology 04 December 2009 Pages: 941 - 941
Author Reply: Follow-Up for Gastric Cancer: How Extensive and Intensive Should It Be? Hoon HurKyo Young SongHae Myung Jeon Gastrointestinal Oncology 10 December 2009 Pages: 942 - 942
Stage and Microscopic Positive Margins in the Treatment of Patients with Gastric Cancer Zhe SunHui-mian Xu Letter to the Editor 29 December 2009 Pages: 943 - 945
Emphasis on Preventing Microscopic Positive Margins in Gastric Cancer J. Spiliotis Gastrointestinal Oncology 21 January 2010 Pages: 946 - 946
